Article
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
Journal of the National Cancer Institute - 1 Dec 2017
Wyatt Alexander W, Annala Matti, Aggarwal Rahul, Beja Kevin, Feng Felix, Youngren Jack, Foye Adam, Lloyd Paul, Nykter Matti, Beer Tomasz M, Alumkal Joshi J, Thomas George V, Reiter Robert E, Rettig Matthew B, Evans Christopher P, Gao Allen C, Chi Kim N, Small Eric J, Gleave Martin E
Abstract excerpt
BACKGROUND: Real-time knowledge of the somatic genome can influence management of patients with metastatic castration-resistant prostate cancer (mCRPC). While routine metastatic tissue biopsy is challenging in mCRPC, plasma circulating tumor DNA (ctDNA) has emerged as a minimally invasive tool to sample the tumor genome. However, no systematic comparisons of matched "liquid" and "solid" biopsies have been...
Topics
Join the communities discussing this publication.
